Journal articles
The Effects of Physician and Hospital Integration on Medicare Beneficiaries' Health Outcomes
Thomas G Koch, Brett W Wendling, Nathan E Wilson
The Review of Economics and Statistics, 2020, pp. 1--38
Physician market structure, patient outcomes, and spending: an examination of Medicare beneficiaries
Thomas Koch, Brett Wendling, Nathan E Wilson
Health services research, vol. 53, Wiley Online Library, 2018, pp. 3549--3568
Estimating the causal effect of entry on generic drug prices using Hatch-Waxman exclusivity
Luke M Olson, Brett W Wendling
Review of Industrial Organization, vol. 53, Springer, 2018, pp. 139--172
How vertical integration affects the quantity and cost of care for Medicare beneficiaries
Thomas G Koch, Brett W Wendling, Nathan E Wilson
Journal of health economics, vol. 52, Elsevier, 2017, pp. 19--32
Entry threats and pricing in the generic drug industry
Steven Tenn, Brett W Wendling
Review of Economics and Statistics, vol. 96, The MIT Press, 2014, pp. 214--228
Julie A Carlson, Leemore S Dafny, Beth A Freeborn, Pauline M Ippolito, Brett W Wendling
Review of Industrial Organization, vol. 43, Springer, 2013, pp. 303--326
Informing the uninformed: How drug advertising affects check-up visits
Daniel Hosken, Brett Wendling
International journal of industrial organization, vol. 31, Elsevier, 2013, pp. 181--194
Economics at the FTC: Drug and PBM mergers and drip pricing
Howard A Shelanski, Joseph Farrell, Daniel Hanner, Christopher J Metcalf, Mary W Sullivan, Brett W Wendling
Review of Industrial Organization, vol. 41, Springer, 2012, pp. 303--319
Economics at the FTC: Hospital mergers, authorized generic drugs, and consumer credit markets
Joseph Farrell, David J Balan, Keith Brand, Brett W Wendling
Review of Industrial Organization, vol. 39, Springer, 2011, pp. 271--296
The role of education in the production of health: An empirical analysis of smoking behavior
Steven Tenn, Douglas A Herman, Brett Wendling
Journal of Health Economics, vol. 29, Elsevier, 2010, pp. 404--417
Matthew C Farrelly, Jeremy W Bray, Gary A Zarkin, Brett W Wendling
Journal of health economics, vol. 20, Elsevier, 2001, pp. 51--68
Thomas J Hoerger, Kristen E Downs, Mark C Lakshmanan, Richard C Lindrooth, LEO Plouffe Jr, Brett Wendling, Suzanne L West, Robert L Ohsfeldt
Journal of women's health \& gender-based medicine, vol. 8, 1999, pp. 1077--1089
Book chapters, government reports, and other publications
Francine Lafontaine, Christopher J. Metcalf, David R. Schmidt, Brett W. Wendling
The Antitrust Revolution, 7th edition, 2018
The Importance of Substitution in Assessing Health Care Provider Mergers
Brett W Wendling, Nathan E Wilson
The Antitrust Bulletin, vol. 59, SAGE Publications Sage CA: Los Angeles, CA, 2014, pp. 515--525
Authorized generic drugs: short-term effects and long-term impact
Federal Trade Commission, others
Retrieved September, vol. 10, 2011, p. 2014
Authorized generics: an interim report
Federal Trade Commission, Federal Trade Commission, others
FTC study. US Government Printing Office, Washington, DC, June, 2009